241 related articles for article (PubMed ID: 25403235)
1. Urinary interleukin-1β levels among gynecological patients.
Woolery KT; Hoffman MS; Kraft J; Nicosia SV; Kumar A; Kruk PA
J Ovarian Res; 2014 Nov; 7():104. PubMed ID: 25403235
[TBL] [Abstract][Full Text] [Related]
2. Increases urinary HMGA1 in serous epithelial ovarian cancer patients.
Zhou J; Xie M; He H; Shi Y; Luo B; Gong G; Li J; Wang J; Wu X; Wen J
Cancer Biomark; 2015; 15(3):325-31. PubMed ID: 25586095
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
4. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
5. Expression of IL-10 in patients with ovarian carcinoma.
Mustea A; Könsgen D; Braicu EI; Pirvulescu C; Sun P; Sofroni D; Lichtenegger W; Sehouli J
Anticancer Res; 2006; 26(2C):1715-8. PubMed ID: 16617566
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and Clinical Value of Interleukin 6 and CD45
Wertel I; Suszczyk D; Pawłowska A; Bilska M; Chudzik A; Skiba W; Paduch R; Kotarski J
J Immunol Res; 2020; 2020():1715064. PubMed ID: 33062717
[TBL] [Abstract][Full Text] [Related]
7. [Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients].
Lyu N; Yao H; Xiao T; Gao Y; Wu L
Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):679-84. PubMed ID: 26675395
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of Bcl-2 are elevated in ovarian cancer patients.
Anderson NS; Bermudez Y; Badgwell D; Chen R; Nicosia SV; Bast RC; Kruk PA
Gynecol Oncol; 2009 Jan; 112(1):60-7. PubMed ID: 19007973
[TBL] [Abstract][Full Text] [Related]
9. Increased RHAMM expression relates to ovarian cancer progression.
Buttermore ST; Hoffman MS; Kumar A; Champeaux A; Nicosia SV; Kruk PA
J Ovarian Res; 2017 Sep; 10(1):66. PubMed ID: 28954627
[TBL] [Abstract][Full Text] [Related]
10. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis.
Petri AL; Simonsen AH; Høgdall E; Christensen IJ; Kjaer SK; Yip C; Risum S; Pedersen AT; Hartwell D; Fung ET; Høgdall C
Proteomics Clin Appl; 2010 Mar; 4(3):304-14. PubMed ID: 21137051
[TBL] [Abstract][Full Text] [Related]
11. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer.
Sallinen H; Heikura T; Laidinen S; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
Int J Gynecol Cancer; 2010 Dec; 20(9):1498-505. PubMed ID: 21119365
[TBL] [Abstract][Full Text] [Related]
12. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates.
Liao JB; Yip YY; Swisher EM; Agnew K; Hellstrom KE; Hellstrom I
Gynecol Oncol; 2015 Jun; 137(3):430-5. PubMed ID: 25866324
[TBL] [Abstract][Full Text] [Related]
13. Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.
Drenberg CD; Saunders BO; Wilbanks GD; Chen R; Nicosia RF; Kruk PA; Nicosia SV
Gynecol Oncol; 2010 Apr; 117(1):117-24. PubMed ID: 20071014
[TBL] [Abstract][Full Text] [Related]
14. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
[TBL] [Abstract][Full Text] [Related]
17. Urinary Polyamines as Biomarkers for Ovarian Cancer.
Niemi RJ; Roine AN; Häkkinen MR; Kumpulainen PS; Keinänen TA; Vepsäläinen JJ; Lehtimäki T; Oksala NK; Mäenpää JU
Int J Gynecol Cancer; 2017 Sep; 27(7):1360-1366. PubMed ID: 28604456
[TBL] [Abstract][Full Text] [Related]
18. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.
Malekzadeh M; Dehaghani AS; Ghaderi A; Doroudchi M
Cancer Biomark; 2013 Jan; 13(6):417-25. PubMed ID: 24595078
[TBL] [Abstract][Full Text] [Related]
19. An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy.
Lee SW; Lee HY; Bang HJ; Song HJ; Kong SW; Kim YM
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590408
[TBL] [Abstract][Full Text] [Related]
20. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients.
Dalal V; Kumar R; Kumar S; Sharma A; Kumar L; Sharma JB; Roy KK; Singh N; Vanamail P
Clin Chim Acta; 2018 Jul; 482():27-32. PubMed ID: 29572186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
